Clade-related amphotericin B resistance among South African Candida albicans isolates

Diagnostic Microbiology and Infectious Disease

Volumn 53, Issue 1, 2005, Pages 29-31

  Blignaut, Elaine ^a   Molepo, Julitha ^a   Pujol, Claude ^b   Soll, David R ^b   Pfaller, Michael A ^c  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Amphotericin B; Antifungal resistance; Candida albicans; Clade relationship; Oral yeasts; South Africa

Indexed keywords

AMPHOTERICIN B;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CLADISTICS; DNA FINGERPRINTING; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DNA FINGERPRINTING; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; HUMANS; SOUTH AFRICA;

EID: 25144434211     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2005.03.013     Document Type: Article

References (23)

1. J. Anderson, T. Srikantha, B. Morrow, S.H. Miyasaki, T.C. White, N. Agabian, J. Schmid, and D.R. Soll Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans J. Clin. Microbiol. 31 1993 1472 1480
2. T.M. Arendorf, B. Bredekamp, C.A. Cloete, and G. Sauer Oral manifestations of HIV infection in 600 South African patients J. Oral Pathol. Med. 27 1998 176 179
3. E. Blignaut, and M. Botes The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients SADJ 54 1999 605 608
4. E. Blignaut, S. Messer, R.J. Hollis, and M.A. Pfaller Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals Diagn. Microbiol. Infect. Dis. 44 2002 169 174
5. E. Blignaut, C. Pujol, S. Lockhart, S. Joly, and D.R. Soll Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa J. Clin. Microbiol. 40 2002 826 836
6. E. Blignaut, C. Pujol, S. Joly, and D.R. Soll Racial distribution of Candida dubliniensis colonization among South Africans J. Clin. Microbiol. 41 2003 1838 1842
7. N.S. Dar-Odeh, and A.A. Shehabi Oral candidosis in patients with removable dentures Mycoses 46 2003 187 191
8. R.A. Hajjeh, A.N. Sofair, L.H. Harrison, G.M. Lyon, B.A. Arthington-Skaggs, S.A. Mirza, M. Phelan, J. Morgan, W. Lee-Yang, M.A. Ciblak, L.E. Benjamin, L.T. Sanza, S. Huie, S.F. Yeo, M.E. Brandt, and D.W. Warnock Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program J. Clin. Microbiol. 42 2004 1519 1527
9. S.R. Lockhart, J.J. Fritch, A.S. Meier, K. Schroppel, T. Srikantha, R. Galask, and D.R. Soll Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing J. Clin. Microbiol. 33 1995 1501 1509
10. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing for yeasts (Document M27-A2) 2002 NCCLS Wayne, PA
11. M.A. Pfaller Epidemiology of nosocomial candidiasis: the importance of molecular typing Braz. J. Infect. Dis. 4 2000 161 167
12. G. Pizzo, F. Barchiesi, L. Falconi Di Francesco, G. Giuliana, D. Arzeni, M.E. Milici, M. D'Angelo, and G. Scalise Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates Arch. Oral Biol. 47 2002 189 196
13. C. Pujol, S. Joly, B. Nolan, T. Srikantha, and D.R. Soll Microevolutionary changes in Candida albicans identified by the complex Ca3 fingerprinting probe involve insertions and deletions of the full-length repetitive sequence RPS at specific genomic sites Microbiology 145 1999 2635 2646
14. C. Pujol, M. Pfaller, and D.R. Soll Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade J. Clin. Microbiol. 40 2002 2729 2740
15. C. Pujol, M.A. Pfaller, and D.R. Soll Flucytosine resistance is restricted to a single genetic clade of Candida albicans Antimicrob. Agents Chemother. 48 2004 262 266
16. V. Ramirez-Amador, L. Esquivel-Pedraza, J. Sierra-Madero, G. Anaya-Saavedra, I. Gonzalez-Ramirez, and S. Ponce-de-Leon The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico Medicine 82 2003 39 50
17. J.H. Rex, C.R. Cooper Jr, W.G. Merz, J.N. Galgiani, and E.J. Anaissie Detection of amphotericin B-resistant Candida isolates in a broth-based system Antimicrob. Agents Chemother. 39 1995 906 909
18. D. Sanglard, and F.C. Odds Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences Lancet Infect. Dis. 2 2002 73 85
19. S. Scherer, and D.A. Stevens Application of DNA fingerprinting methods to epidemiology and taxonomy of Candida species J. Clin. Microbiol. 25 1987 675 679
20. J.D. Sobel, S.E. Ohmit, P. Schuman, J.A. Vazquez, R.S. Klein, K. Mayer, A. Duerr, and A. Rompalo The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women J. Infect. Dis. 183 2000 286 293
21. D.R. Soll The ins and outs of DNA fingerprinting the infectious fungi Clin. Microbiol. Rev. 13 2000 332 370
22. D.R. Soll, and C. Pujol Candida albicans clades FEMS Immunol. Med. Microbiol. 39 2003 1 7
23. T.M. Waltimo, D. Orstavik, J.H. Meurman, L.P. Samaranayake, and M.P. Haapasalo In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents Oral Microbiol. Immunol. 15 2000 245 248